cepharanthine has been researched along with 2019 Novel Coronavirus Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 10 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hijikata, A; Hirokawa, T; Kanaya, S; Nakae, S; Nakajima, S; Ota, M; Shionyu, M; Shionyu-Mitsuyama, C; Shirai, T; Watashi, K | 1 |
| Chen, G; Dou, G; Gan, H; Gu, R; Han, P; Li, J; Liu, T; Meng, Z; Wang, F; Wu, Z; Zhu, X | 1 |
| Fan, H; Han, P; He, ST; Hong, B; Li, M; Liu, K; Tong, Y; Wang, S | 1 |
| Fan, H; Han, P; He, S; Hong, B; Li, M; Liu, K; Tong, Y; Wang, S | 1 |
| Dou, G; Du, L; Li, Q; Liang, D | 1 |
| Chen, G; Dou, G; Gan, H; Gu, R; Han, P; Li, J; Liang, D; Liu, H; Liu, M; Liu, S; Liu, T; Meng, Z; Wu, Z; Zhou, H; Zhu, X | 1 |
| Chen, Y; Li, Y; Liu, Z; Shi, L; Wang, J; Wang, S; Wei, B; Zhang, L; Zhang, S; Zhao, S | 1 |
| Fan, H; Hong, B; Hu, R; Liu, K; Lou, F; Shafqat, A; Tong, Y; Wang, S; You, Y | 1 |
| Ballout, RA; Bukrinsky, MI; Remaley, AT; Sviridov, D | 1 |
| Koman, I; Okediji, P; Rogosnitzky, M | 1 |
4 review(s) available for cepharanthine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Pharmacological Effects and Clinical Prospects of Cepharanthine.
Topics: Alkaloids; Antiviral Agents; Benzylisoquinolines; COVID-19; Humans | 2022 |
Research progress on pharmacological effects and mechanisms of cepharanthine and its derivatives.
Topics: Alkaloids; Apoptosis; Benzylisoquinolines; COVID-19; Humans | 2023 |
Pharmacological Activity of Cepharanthine.
Topics: Alkaloids; Antiviral Agents; Benzylisoquinolines; COVID-19; Humans; SARS-CoV-2 | 2023 |
Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.
Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Benzylisoquinolines; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Inflammation; Japan; SARS-CoV-2; Virus Replication | 2020 |
6 other study(ies) available for cepharanthine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2.
Topics: Animals; Antiviral Agents; Benzylisoquinolines; Chlorocebus aethiops; Coronavirus M Proteins; COVID-19; Drug Evaluation, Preclinical; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Plant Preparations; Protein Binding; Protein Conformation; SARS-CoV-2; Stephania; Vero Cells | 2022 |
Bioavailability Enhancement of Cepharanthine via Pulmonary Administration in Rats and Its Therapeutic Potential for Pulmonary Fibrosis Associated with COVID-19 Infection.
Topics: Animals; Benzylisoquinolines; Biological Availability; Bleomycin; Chromatography, Liquid; COVID-19; COVID-19 Drug Treatment; Humans; Lung; Pulmonary Fibrosis; Rats; Tandem Mass Spectrometry; Transforming Growth Factor beta1 | 2022 |
Cepharanthine: A Promising Old Drug against SARS-CoV-2.
Topics: Antiviral Agents; Benzylisoquinolines; COVID-19; Humans; SARS-CoV-2 | 2022 |
[Progress in the study of antiviral activity of cepharanthine against SARS-CoV-2].
Topics: Antiviral Agents; Benzylisoquinolines; COVID-19; Humans; SARS-CoV-2 | 2022 |
Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation.
Topics: Animals; Bleomycin; Collagen; COVID-19; Fibroblasts; Inflammation; Lung; Myofibroblasts; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Pulmonary Fibrosis; Rats; Transforming Growth Factor beta1 | 2023 |
The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.
Topics: ADAM17 Protein; Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Benzylisoquinolines; Betacoronavirus; Biological Transport; Cathepsin L; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Endocytosis; Endosomes; Glycopeptides; Humans; Hydroxychloroquine; Intracellular Signaling Peptides and Proteins; Lysosomes; Membrane Lipids; Membrane Microdomains; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Oxysterols; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; SARS-CoV-2; Serine Endopeptidases; Triazoles; Virus Internalization | 2020 |